Skip to main content
. 2023 Oct 1;49(10):440–445. doi: 10.14745/ccdr.v49i10a05

Figure 2.

Figure 2

Age distribution of nirmatrelvir/ritonavir (PaxlovidTM) recipients, Canadaa, 2022 (n=61,413)

a Based on data from eight reporting jurisdictions